A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 2,000 shares of TEVA stock, worth $35,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,500 20.0%
Holding current value
$35,000
Previous $35,000 5.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.78 - $17.4 $6,390 - $8,700
-500 Reduced 20.0%
2,000 $33,000
Q3 2021

Nov 02, 2021

SELL
$8.38 - $10.18 $5,028 - $6,108
-600 Reduced 19.35%
2,500 $24,000
Q2 2021

Aug 11, 2021

BUY
$9.9 - $11.56 $24,750 - $28,900
2,500 Added 416.67%
3,100 $31,000
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $6,204 - $7,686
600 New
600 $7,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $2,152 - $2,760
-250 Closed
0 $0
Q4 2019

Feb 06, 2020

SELL
$6.53 - $10.72 $1,959 - $3,216
-300 Reduced 54.55%
250 $2,000
Q3 2019

Nov 05, 2019

SELL
$6.16 - $9.6 $1,232 - $1,920
-200 Reduced 26.67%
550 $4,000
Q2 2019

Aug 08, 2019

SELL
$8.12 - $15.72 $9,955 - $19,272
-1,226 Reduced 62.04%
750 $7,000
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $121,601 - $156,178
-7,805 Reduced 79.8%
1,976 $31,000
Q4 2018

Jan 31, 2019

SELL
$14.59 - $23.84 $139,042 - $227,195
-9,530 Reduced 49.35%
9,781 $151,000
Q3 2018

Oct 29, 2018

SELL
$21.06 - $25.65 $64,232 - $78,232
-3,050 Reduced 13.64%
19,311 $416,000
Q2 2018

Jul 19, 2018

BUY
$16.77 - $24.71 $317,590 - $467,957
18,938 Added 553.26%
22,361 $544,000
Q1 2018

Apr 17, 2018

BUY
$16.68 - $22.07 $18,314 - $24,232
1,098 Added 47.23%
3,423 $58,000
Q4 2017

Jan 17, 2018

SELL
$11.23 - $19.1 $15,396 - $26,186
-1,371 Reduced 37.09%
2,325 $44,000
Q3 2017

Oct 24, 2017

BUY
$15.41 - $32.17 $56,955 - $118,900
3,696
3,696 $65,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.